These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35814424)

  • 21. Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model.
    Nie S; Huili Y; He Y; Hu J; Kang S; Cao F
    Front Surg; 2022; 9():860857. PubMed ID: 35478725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma.
    Zhao Z; Shen X; Zhao S; Wang J; Tian Y; Wang X; Tang B
    Aging (Albany NY); 2023 Nov; 15(22):12927-12951. PubMed ID: 37976136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer.
    Yang Z; Li J; Tang Y; Zou L
    Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of
    Xiang X; Gao LM; Zhang Y; Tang Y; Zhao S; Liu W; Ye Y; Zhang W
    Front Genet; 2022; 13():849422. PubMed ID: 35711924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
    Peng YL; Wang LX; Li MY; Liu LP; Li RS
    PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
    Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
    Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status.
    Cao X; He J; Chen A; Ran J; Li J; Chen D; Zhang H
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma.
    Jiang JY; Yao FY; Liu J; Wang XL; Huang B; Zhong FM; Wang XZ
    Technol Cancer Res Treat; 2024; 23():15330338241232554. PubMed ID: 38361483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma.
    Wu W; Wang J; Jiang Y; Hu X; Tian Y; Chen L; Sun H; Li Y; Liu S; Lv Y; Guo J; Xu H; Xing D; Zhai Y; Tian L; Li C; He X; Luo K; Pan Y; Zhao Z
    J Cancer; 2023; 14(3):403-416. PubMed ID: 36860924
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
    Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
    Front Immunol; 2022; 13():964118. PubMed ID: 36059470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
    Zheng C; Guo H; Mo Y; Liu G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):681-694. PubMed ID: 37653627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening of Differential Expression Autophagy Genes Related to the Prognosis of Diffuse Large B-Cell Lymphoma and Establishment of an Autophagy Model].
    Zhang JD; Zhang HM; Lu D; Wang ZN; Chen HR; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1101-1108. PubMed ID: 35981368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment.
    Cui Y; Leng C
    Front Cell Dev Biol; 2023; 11():1070777. PubMed ID: 36755971
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma.
    Zhang J; He X; Hu J; Li T
    Front Genet; 2022; 13():920350. PubMed ID: 35754848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients.
    Hua L; Lei P; Hu Y
    Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
    Li Z; Yang W; Liu D; Ye W; Du G; Li X
    Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
    Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
    J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.